Literature DB >> 20046154

Estimation of antiretroviral therapy coverage: methodology and trends.

Mary Mahy1, Jean-Michel Tassie, Peter D Ghys, John Stover, Michel Beusenberg, Priscilla Akwara, Yves Souteyrand.   

Abstract

PURPOSE OF REVIEW: To present the methodology used to calculate coverage of antiretroviral therapy (ART) and review global and regional trends in ART coverage. RECENT
FINDINGS: There has been a steady increase in ART coverage over the last decade with a more rapid increase in recent years. Current estimates of ART coverage are 43% for adults and 38% for children (ages 0-14 years). Methods for calculating coverage rely on good-quality patient monitoring systems in countries, and well informed models are needed to estimate the number of people in need of treatment.
SUMMARY: The estimated coverage rates show that ART programs have improved over the past 8 years; however, approximately 58% (53-60%) of those people in need of ART are still not on treatment. High quality data are needed to accurately measure changes in ART coverage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20046154     DOI: 10.1097/COH.0b013e328333b892

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  11 in total

1.  How should access to antiretroviral treatment be measured?

Authors:  Leigh F Johnson; Andrew Boulle
Journal:  Bull World Health Organ       Date:  2011-02-01       Impact factor: 9.408

2.  Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043).

Authors:  Jessica M Fogel; William Clarke; Michal Kulich; Estelle Piwowar-Manning; Autumn Breaud; Matthew T Olson; Mark A Marzinke; Oliver Laeyendecker; Agnès Fiamma; Deborah Donnell; Jessie K K Mbwambo; Linda Richter; Glenda Gray; Michael Sweat; Thomas J Coates; Susan H Eshleman; Alfred H Chingono
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

Review 3.  Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection.

Authors:  Jordan Poles; Yelina Alvarez; Catarina E Hioe
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11       Impact factor: 2.205

4.  Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low- and middle-income countries.

Authors:  Jean-Michel Tassie; Karen Malateste; Mar Pujades-Rodríguez; Elisabeth Poulet; Diane Bennett; Anthony Harries; Mary Mahy; Mauro Schechter; Yves Souteyrand; François Dabis
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

5.  Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults.

Authors:  Mary Mahy; John Stover; Karen Stanecki; Rand Stoneburner; Jean-Michel Tassie
Journal:  Sex Transm Infect       Date:  2010-12       Impact factor: 3.519

6.  A retrospective review of patients with Kaposi's sarcoma in Botswana.

Authors:  Christa Slaught; Victoria Williams; Surbhi Grover; Elizabeth Bigger; Mukendi Kayembe; Sebathu Chiyapo; Nicholas J Jackson; Scott Dryden-Peterson; Carrie L Kovarik; Karolyn A Wanat
Journal:  Int J Dermatol       Date:  2018-11-21       Impact factor: 3.204

7.  Access to, and uptake of, antiretroviral therapy in a developing country with high HIV prevalence: a population-based cohort study in rural Uganda, 2004-2008.

Authors:  Patrick Kazooba; Ivan Kasamba; Kathy Baisley; Billy N Mayanja; Dermot Maher
Journal:  Trop Med Int Health       Date:  2012-08       Impact factor: 2.622

8.  Is endemic political corruption hampering provision of ART and PMTCT in developing countries?

Authors:  Wing Young Nicola Man; Heather Worth; Angela Kelly; David P Wilson; Peter Siba
Journal:  J Int AIDS Soc       Date:  2014-05-02       Impact factor: 5.396

9.  Late presentation for HIV care in Southwest Ethiopia in 2003-2015: prevalence, trend, outcomes and risk factors.

Authors:  Hailay Abrha Gesesew; Paul Ward; Kifle Woldemichael; Lillian Mwanri
Journal:  BMC Infect Dis       Date:  2018-01-30       Impact factor: 3.090

Review 10.  Monitoring intervention coverage in the context of universal health coverage.

Authors:  Ties Boerma; Carla AbouZahr; David Evans; Tim Evans
Journal:  PLoS Med       Date:  2014-09-22       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.